Measles Clinical Manifestations
Measles (rubeola) presents with a characteristic clinical triad: high fever (≥101°F/38.3°C), generalized rash lasting ≥3 days, and at least one of the "three Cs" - cough, coryza (runny nose), or conjunctivitis. 1
Incubation and Timeline
The incubation period averages 10-12 days from exposure to prodrome and 14 days from exposure to rash (range: 7-18 days). 1
Clinical Presentation
Prodromal Phase
- High fever (≥38.3°C/101°F)
- Cough, coryza (runny nose), and/or conjunctivitis - the classic "three Cs"
- Koplik spots (pathognomonic enanthem) - small white spots on buccal mucosa 2
Rash Phase
- Appears 3-4 days after prodrome onset 3
- Erythematous, maculopapular rash
- Begins on the face and spreads cephalocaudally (head to toe)
- Becomes more confluent as it spreads 2
- Lasts ≥3 days 1
Complications and Mortality
Measles can be severe, with complications occurring in 10-40% of patients 2:
Common Complications
- Diarrhea
- Middle ear infection (otitis media)
- Bronchopneumonia 1
Severe Complications
- Encephalitis: occurs in approximately 1 in 1,000 cases; survivors often have permanent brain damage and mental retardation 1
- Death: occurs in 1-2 per 1,000 cases in the United States
- Most common causes of death are pneumonia and acute encephalitis 1
High-Risk Populations
Infants, young children, and adults have greater risk for death and complications than older children and adolescents 1.
Immunocompromised persons (leukemia, lymphoma, HIV infection) may experience:
- Severe and prolonged disease
- Measles without typical rash
- Viral shedding for several weeks after acute illness 1
Late Complication
Subacute sclerosing panencephalitis (SSPE): rare degenerative CNS disease appearing years after measles infection; essentially eliminated in the U.S. due to vaccination 1
Pregnancy Complications
- Increased rates of premature labor
- Spontaneous abortion
- Low birth weight 1
Diagnosis
Laboratory Confirmation
The laboratory criteria include 1:
- Positive measles IgM antibody (preferred initial test)
- Significant rise in measles IgG between acute and convalescent sera
- Isolation of measles virus from clinical specimen
- Detection of measles RNA by RT-PCR 2
Critical Timing for Serologic Testing
- Collect blood during first clinical encounter
- Use direct-capture IgM EIA method (sensitive and specific)
- IgM may not be detectable until 72 hours after rash onset with some assays
- If negative in first 72 hours, repeat testing ≥72 hours after rash onset
- IgM peaks at ~10 days after rash onset
- IgM detectable for at least 1 month after rash onset 1
Important caveat: As measles becomes rare, false-positive IgM results increase. 1
Management
Treatment is primarily supportive - no specific antiviral therapy exists 3:
- Symptomatic care
- Vitamin A supplementation recommended 4
- Treat bacterial superinfections with antibiotics 2
- Respiratory and hemodynamic support for severe cases 4
- Neurological monitoring for complications 4
Infection Control
Immediate isolation and reporting to local/state health department is mandatory upon suspicion or confirmation of measles 1. This is critical given measles is among the most contagious human diseases 4.
Prevention Priority
Prevention through vaccination has absolute priority given the lack of specific treatment and significant morbidity/mortality 3. The disease has shown concerning resurgence despite being vaccine-preventable, with declining vaccination rates driving recent outbreaks 5, 4, 6.